University of Manchester

NAVEE S65 - The Futuristic Electric Scooter Elevates Urban Commute

Retrieved on: 
Wednesday, June 8, 2022
WILD, St. Martin's, Sharp EL-500W series, MSRP, Patent, N65, The, City, Duke University, University of Manchester, University, GLOBE, Tsinghua University, Risk, Weather, Motor vehicle, S65, Industry, Stanford University, IPX5, OEM, Safety, Car rental, Road, Taxicab, Ridesharing company, Indiegogo, New York University

NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- NAVEE, a rising star in the e-mobility industry, has just launched its latest product, the NAVEE S65 Electric Scooter, and people are head over toes about this unique city commuter.

Key Points: 
  • NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- NAVEE, a rising star in the e-mobility industry, has just launched its latest product, the NAVEE S65 Electric Scooter, and people are head over toes about this unique city commuter.
  • This new electric scooter not only offers a one-of-a-kind riding experience, but it is also feature-rich, powerful, and cost-effective, making the crowds go WILD!
  • Although there are many different electric scooters on the market, the NAVEE S65 E-scooter differs from others for a few reasons.
  • The NAVEE S65 Electric Scooter is now available on Indiegogo for $599 at Super Early Bird prices.

University of Manchester Adds Carterra’s LSA® Instrument for High-Throughput Antibody Screening and Characterization

Retrieved on: 
Wednesday, June 8, 2022
Science, Biotechnology, Research, Pharmaceutical, Health, Medical Devices, University, Education, Manchester, University of Manchester, Eli Lilly, Cros, Time, Mab, Research, PerkinElmer, Immunoassay, Čović, Social responsibility, Software, AbCellera, Partnership, Wellcome Trust, NHS, University, Method, Faculty, LSA, Technology, COVID-19, Antibody, Bamlanivimab, Industry, Tissue, Microfluidics, Surface plasmon resonance, Education, VHH, Pharmaceutical industry, Fine chemical, Biochemistry, Biology, Medicine, Health

The BACF also supports research at other higher education institutions in the UK as well as in the pharmaceutical industry.

Key Points: 
  • The BACF also supports research at other higher education institutions in the UK as well as in the pharmaceutical industry.
  • The LSA will allow university researchers to cast a wider net and screen more nanobodies per target, thereby increasing the likelihood of identifying the ideal hit.
  • We cant wait to use the LSA for our development and characterization of nanobodies for which Carterras instrument is perfectly suited, commented Dr. Tom Jowitt, the Manager of the BACF.
  • Carterras LSA instrument, software, and consumables for monoclonal antibody (mAb) characterization deliver up to 100 times the throughput of existing platforms in 10% of the time while using only 1% of the sample required by other systems.

RealVNC to Test Cybersecurity Technologies of the Future from the University of Cambridge and Arm

Retrieved on: 
Tuesday, June 7, 2022
Software, Technology, Data Management, Security, Digital Catapult, NCSC, Computer, University of Oxford, Arm, VNC, The Sensorites, University of Edinburgh, Software, University of Cambridge, Government, University of Manchester, Digital, University, Brain, Architecture, DataCore, Technology, Digital security, SRI International, Innovation, Hewlett-Packard, Innovate UK, National Cyber Security Centre (Ireland), Microsoft, National, King's College London, Design, Online shopping, RealVNC, Google, Thales of Miletus, Oldbury

The technology was co-developed by University of Cambridge researchers (with colleagues at SRI International) in collaboration with Arm.

Key Points: 
  • The technology was co-developed by University of Cambridge researchers (with colleagues at SRI International) in collaboration with Arm.
  • Thats why were thrilled to help Digital Catapult ensure next-generation technologies are safe from security threats, said RealVNC CEO Adam Greenwood-Byrne.
  • RealVNC will test and evaluate these technologies within its own business and provide its findings back to the programme, which could influence the design of future and more secure computer systems.
  • RealVNC and the other participating companies will have access to the technologies as well as up to 15,000 in funding to support their experimentation period.

NAG Appoints RWTH Aachen University Professor Uwe Naumann as Principal Scientist, expanding long standing strategic partnership

Retrieved on: 
Monday, May 9, 2022
Cloud, Software, University, Turing Award, German Centre for Integrative Biodiversity Research (iDiv), ACM, INRIA, Numerical Algorithms Group, Engineering, RWTH Aachen University, Research, Mathematical optimization, Dresden University of Technology, Doctor of Philosophy, Differentiable function, University of Hertfordshire, HPC, Mathematics, Program, Applied mathematics, Ternopil Ivan Pul'uj National Technical University, Centre for Excellence in Basic Sciences, Center, Numerical, Analysis, University of California, San Diego, Knowledge, Computer science, Argonne National Laboratory, Machine learning, RWTH, NAG, Education, ACDA, University of Manchester, Software engineering, CEO, University of Oxford, Collection, Automatic differentiation, National university, Management, EU

OXFORD, England and AACHEN, Germany, May 9, 2022 /PRNewswire/ -- Today, the Numerical Algorithms Group (NAG) announced the appointment of RWTH Aachen University Professor Uwe Naumann as Principal Scientist.

Key Points: 
  • OXFORD, England and AACHEN, Germany, May 9, 2022 /PRNewswire/ -- Today, the Numerical Algorithms Group (NAG) announced the appointment of RWTH Aachen University Professor Uwe Naumann as Principal Scientist.
  • In this role Prof Naumann will help drive the next generation of technical products at NAG through his extensive knowledge of technical and scientific computing and Automatic Differentiation.
  • I am delighted that Professor Naumann will become our first Principal Scientist.
  • Uwe Naumann has been a professor of Computer Science at RWTH Aachen University, Germany, since 2004 and a member of NAG since 2010.

NAG Appoints RWTH Aachen University Professor Uwe Naumann as Principal Scientist, expanding long standing strategic partnership

Retrieved on: 
Monday, May 9, 2022
Cloud, Software, University, Turing Award, German Centre for Integrative Biodiversity Research (iDiv), ACM, INRIA, Numerical Algorithms Group, Engineering, RWTH Aachen University, Research, Mathematical optimization, Dresden University of Technology, Doctor of Philosophy, Differentiable function, University of Hertfordshire, HPC, Mathematics, Program, Applied mathematics, Ternopil Ivan Pul'uj National Technical University, Centre for Excellence in Basic Sciences, Center, Numerical, Analysis, University of California, San Diego, Knowledge, Computer science, Argonne National Laboratory, Machine learning, RWTH, NAG, Education, ACDA, University of Manchester, Software engineering, CEO, University of Oxford, Collection, Automatic differentiation, National university, Management, EU

OXFORD, England and AACHEN, Germany, May 9, 2022 /PRNewswire/ -- Today, the Numerical Algorithms Group (NAG) announced the appointment of RWTH Aachen University Professor Uwe Naumann as Principal Scientist.

Key Points: 
  • OXFORD, England and AACHEN, Germany, May 9, 2022 /PRNewswire/ -- Today, the Numerical Algorithms Group (NAG) announced the appointment of RWTH Aachen University Professor Uwe Naumann as Principal Scientist.
  • In this role Prof Naumann will help drive the next generation of technical products at NAG through his extensive knowledge of technical and scientific computing and Automatic Differentiation.
  • I am delighted that Professor Naumann will become our first Principal Scientist.
  • Uwe Naumann has been a professor of Computer Science at RWTH Aachen University, Germany, since 2004 and a member of NAG since 2010.

New Adventure in the ZIBS Metaverse Campus

Retrieved on: 
Friday, April 29, 2022
Education, Technology, Audio, Video, Software, Continuing, University, Tao, Online, Zhejiang University, CTO, The Lego Movie: 4D – A New Adventure, University, Director general, World Bank Group, Multimedia, ZJU, Industry, Exhibition, Alex Edmans, Sing Tao News Corporation, BEN, HTC, Intelligence, First Step, Virtual reality, Student, London Business School, Goal, Heart, Communication, Technology integration, Interdisciplinarity, ESCP Business School, First Nations in Ontario, International relations, University of Glasgow, Partnership, 125th, Cai Jin, United Nations, Alliance Manchester Business School, Kish International Campus, University of Tehran, International, Entrepreneurship, Adam Smith School of Economics and Finance, University of Manchester, Education, Internet, United Kingdom, Environment, Tutoring, Management, Tourism, Asset management, Yangtze Delta, Metaverse

Zhejiang University International Business School (ZIBS) officially launched its Metaverse Campus!

Key Points: 
  • Zhejiang University International Business School (ZIBS) officially launched its Metaverse Campus!
  • Professor HAN Seung-soo, President of the United Nations General Assemblys 56th session
    The ZIBS Metaverse Campus is a dedication to 125th anniversary of Zhejiang University, and it is an important milestone for us.
  • Sing Tao and ZIBS's collaboration to promote the Metaverse Campus is a breakthrough in the metaverse, aiming to push the media and higher education into a new era.
  • Zhejiang University International Business School (ZIBS) was founded on the Zhejiang University (ZJU) International Campus at Haining in November 2018.

Delphix Accelerates Growth, Profitability for Second Consecutive Year at Scale

Retrieved on: 
Thursday, April 28, 2022
Solution, Fannie Mae, SAP, Awareness, CEO, LinkedIn, Molina Healthcare, Algorithm, Strategic Air Command Digital Information Network, Twitter, TDM, University of Manchester, API, APJ, Michelin, GLOBE, Information, Choice Hotels International, LGPD, Technology, Automation, Growth, VP, Travel, SDK, Privacy, University, Linux, Tesco international operations, IDC, Senior, Data management, Compliance, Microsoft, ARR, Industry, Risk, EMEA, BNP Paribas, Trust, Pharmaceutical industry, Online shopping, Medical device, Management, Sales, Video game console, DevOps, Salesforce, Facebook

Enterprise applications all need test data for fast, quality releases, said Jedidiah Yueh, Delphix Founder and CEO.

Key Points: 
  • Enterprise applications all need test data for fast, quality releases, said Jedidiah Yueh, Delphix Founder and CEO.
  • Delphix helps companies like Banco Carrefour, The University of Manchester, and BNP Paribas release applications quickly while improving data security and compliance.
  • By automating data delivery into test environments, Delphix helps software developers innovate faster while reducing compliance and security risk.
  • Accelerated growth and profitability over the last two years at a scale greater than $100M of annual recurring revenues.

Mitel Expands Range of Phones Built with Plastics Protected with BioCote® Antimicrobials to Include DECT Handsets

Retrieved on: 
Thursday, April 21, 2022
Mobile, Wireless, Networks, General Health, Internet, Consumer Electronics, Technology, Hospitals, Security, Chemicals, Plastics, Manufacturing, Telecommunications, Health, COVID-19, EPA, NHS, Hygiene, ISO, Plastic, Trafford, MZA, Bacteria, Hospital, Engineering, Manchester University NHS Foundation Trust, NHS foundation trust, LinkedIn, Growth, Privacy, Technology, US, DECT, Solution, Security, University of Manchester, Multimedia, GSM, Trafford General Hospital, Virus, View, Mobile phone, Mitel

View the full release here: https://www.businesswire.com/news/home/20220421005010/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220421005010/en/
    Mitels Digital Enhanced Cordless Technology (DECT) 600dt series handsets are protected with BioCote antimicrobial technology for high touch work environments.
  • As part of this strategy, Mitel launched our IP business phones featuring plastics protected with antimicrobial technology last year and are now expanding our device portfolio using antimicrobial plastics to include mobile DECT handsets for use in very high-touch environments.
  • Our latest research1 reveals that Mitel continues to lead the global DECT phones market, with 21% supplier market share, said Peter Hale, principal analyst at MZA.
  • Our Mitel phones provide staff with peace of mind, knowing they have the right telephony equipment to meet their needs.

CellCentric Strengthens Leadership Team

Retrieved on: 
Wednesday, April 6, 2022
Neoplasm, University, D, Lymphatic system, Board, Oncogene, AstraZeneca, Biotechnology, Research, CBP, Cancer, Knowledge, Frese, Cancer research, Cancer Research UK, HPV Prevention and Control Board, Patient, University of Manchester, Pharmaceutical industry, Medical imaging

CellCentric is developing inobrodib, an orally bioavailable drug that is transitioning into Phase II clinical trials in multiple indications.

Key Points: 
  • CellCentric is developing inobrodib, an orally bioavailable drug that is transitioning into Phase II clinical trials in multiple indications.
  • Kris most recently served as an Associate Scientist at Cancer Research UK where he co-led the Cancer Biomarker Centre Preclinical Pharmacology Team.
  • Kris Frese, Director of Cancer Biology of CellCentric said:"I am excited to join CellCentric at this stage of development.
  • CellCentric is a research driven and patient-centric clinical stage, private biotechnology company pioneering small molecule inhibition of the twin proteins, p300/CBP.

CellCentric Strengthens Leadership Team

Retrieved on: 
Wednesday, April 6, 2022
Neoplasm, University, D, Lymphatic system, Board, Oncogene, AstraZeneca, Biotechnology, Research, CBP, Cancer, Knowledge, Frese, Cancer research, Cancer Research UK, HPV Prevention and Control Board, Patient, University of Manchester, Pharmaceutical industry, Medical imaging

CellCentric is developing inobrodib, an orally bioavailable drug that is transitioning into Phase II clinical trials in multiple indications.

Key Points: 
  • CellCentric is developing inobrodib, an orally bioavailable drug that is transitioning into Phase II clinical trials in multiple indications.
  • Kris most recently served as an Associate Scientist at Cancer Research UK where he co-led the Cancer Biomarker Centre Preclinical Pharmacology Team.
  • Kris Frese, Director of Cancer Biology of CellCentric said:"I am excited to join CellCentric at this stage of development.
  • CellCentric is a research driven and patient-centric clinical stage, private biotechnology company pioneering small molecule inhibition of the twin proteins, p300/CBP.